Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev Med Interne ; 21(9): 791-4, 2000 Sep.
Artigo em Francês | MEDLINE | ID: mdl-11039175

RESUMO

INTRODUCTION: Cutaneous necrosis occurring in the course of treatment by alpha interferon is an uncommon side-effect. Its physiopathologic mechanism remains obscure. A local thrombotic action of interferon has been suggested to explain its occurrence. EXEGESIS: A 64-year-old male patient with human immunodeficiency virus-related cutaneous Kaposi's sarcoma presented cutaneous necrosis after a 9-month treatment by interferon alpha, while his resistance to activated protein C had already been demonstrated. To our knowledge, this is the first case ever described regarding the association of interferon-induced cutaneous necrosis with activated protein C resistance. CONCLUSION: This suggests that in case of interferon treatment-induced cutaneous necrosis coagulation disorders should be investigated and questions the existence of a particular "pro-coagulant profile" facilitating this side effect.


Assuntos
Resistência à Proteína C Ativada/complicações , Resistência à Proteína C Ativada/diagnóstico , Antineoplásicos/efeitos adversos , Toxidermias/etiologia , Interferon-alfa/efeitos adversos , Resistência à Proteína C Ativada/sangue , Biópsia , Toxidermias/patologia , Infecções por HIV/complicações , Humanos , Injeções Subcutâneas , Interferon alfa-2 , Masculino , Pessoa de Meia-Idade , Necrose , Proteínas Recombinantes , Sarcoma de Kaposi/terapia , Sarcoma de Kaposi/virologia , Neoplasias Cutâneas/terapia , Neoplasias Cutâneas/virologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...